Content area

|
|

Repetitiv transkraniel magnetisk stimulation til depressionsbehandling

Forfatter(e)
Poul Erik Buchholtz
Afdelingen for Depression og Angst, Aarhus Universitetshospital

Ugeskr Læger 2019;181:V10180699

Reference: 
Ugeskr Læger 2019;181:V10180699

Poul Erik Buchholtz:

Repetitive transcranial magnetic stimulation in the treatment of depression

Ugeskr Læger 2019;181:V10180699

Repetitive transcranial magnetic stimulation (rTMS) has appeared as a new non-invasive antidepressant method, which implies non-convulsive focal stimulation of the brain through a time-varying magnetic field. Research indicates, that rTMS of the prefrontal cortex has a significant antidepressant effect and is associated with minimal side effects. The method has been approved by the Food and Drug Administration in USA and a couple of other countries for the treatment of drug-resistant depressions. The present status on the issue confirms the outcome of previous research and recommends the method as an additional option in the treatment of depression.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Astrid Hanna M. Schulze | 24/08
1 Kommentar
af Benny Andreasson | 23/08
1 Kommentar
af Sven Felsby | 20/08
1 Kommentar
af Christian Visby Carlsen | 20/08
8 kommentarer
af Jørn Rosborg | 18/08
2 kommentarer
af Kasper Broby Eckert | 17/08
3 kommentarer
af Pal Bela Szecsi | 16/08
1 Kommentar
af Michael Prangsgaard Møller | 16/08
2 kommentarer